Lipoprotein (a) and other prothrombotic risk factors in Caucasian women with unexplained recurrent miscarriage. Results of a multicentre case-control study

Thromb Haemost. 2005 May;93(5):867-71. doi: 10.1160/TH04-08-0519.

Abstract

From 1998 to 2003, 133 Caucasian women aged 17-40 years (median 29 years) suffering from unexplained recurrent miscarriage (uRM) were consecutively enrolled. In patients and 133 age-matched healthy controls prothrombotic risk factors (factor V (FV) G1691A, factor II (FII) G20210A, MTHFR T677T, 4G/5G plasminogen activator inhibitor (PAI)-1, lipoprotein (Lp) (a), protein C (PC), protein S (PS), antithrombin (AT), antiphospholipid/anticardiolipin (APA/ACA) antibodies) as well as associated environmental conditions (smoking and obesity) were investigated. 70 (52.6%) of the patients had at least one prothrombotic risk factor compared with 26 control women (19.5%; p<0.0001). Body mass index (BMI; p=0.78) and smoking habits (p=0.44) did not differ significantly between the groups investigated. Upon univariate analysis the heterozygous FV mutation, Lp(a) > 30 mg/dL, increased APA/ACA and BMI > 25 kg/m(2) in combination with a prothrombotic risk factor were found to be significantly associated with uRM. In multivariate analysis, increased Lp(a) (odds ratio (OR): 4.7/95% confidence interval (CI): 2.0-10.7), the FV mutation (OR:3.8/CI:1.4-10.7), and increased APA/ACA (OR: 4.5/CI: 1.1-17.7) had independent associations with uRM.

Publication types

  • Multicenter Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Abortion, Habitual / blood*
  • Abortion, Habitual / diagnosis
  • Adolescent
  • Adult
  • Antibodies, Anticardiolipin / biosynthesis
  • Antibodies, Antiphospholipid / blood
  • Anticoagulants / pharmacology
  • Antithrombins / biosynthesis
  • Body Mass Index
  • Case-Control Studies
  • Factor V / biosynthesis
  • Female
  • Follow-Up Studies
  • Heterozygote
  • Humans
  • Lipoprotein(a) / biosynthesis
  • Lipoprotein(a) / chemistry*
  • Logistic Models
  • Methylenetetrahydrofolate Dehydrogenase (NAD+) / biosynthesis
  • Multivariate Analysis
  • Mutation
  • Odds Ratio
  • Plasminogen Activator Inhibitor 1 / biosynthesis
  • Protein C / biosynthesis
  • Protein S / biosynthesis
  • Prothrombin / biosynthesis
  • Risk Factors
  • Thrombosis / blood*
  • Thrombosis / diagnosis

Substances

  • Antibodies, Anticardiolipin
  • Antibodies, Antiphospholipid
  • Anticoagulants
  • Antithrombins
  • Lipoprotein(a)
  • Plasminogen Activator Inhibitor 1
  • Protein C
  • Protein S
  • Factor V
  • Prothrombin
  • Methylenetetrahydrofolate Dehydrogenase (NAD+)